CME has named Ann Shuman and Kendal Vroman as co-Heads of Corporate Development. Scott Robinson, who currently serves as managing director of Corporate Development, is leaving CME to pursue other business interests.
Shuman and Vroman, who have worked together in CME’s corporate development area in previous roles, will be responsible for the operation of the strategic planning, business development and overall corporate development teams. They will report to CEO Craig Donohue.
“As we continue to selectively seek non-organic growth opportunities through transaction processing, mergers and acquisitions, these enhancements to our Corporate Development Team will ensure that we continue to deliver value to our shareholders,” Donohue said. “Ann and Ken are highly-effective leaders who have already made substantial contributions to the execution of our growth strategy. For example, they both played key roles in our historic clearing agreement with The Chicago Board of Trade(R) and our distribution partnership to provide CME FX on Reuters.”
Additionally, CME appointed Johannes Zhou, who is a leading expert in clearing, settlement and risk management in Asian derivatives markets, as director of Asian Business Development. Zhou previously served in key leadership roles for the Hong Kong Futures Exchange, including Chief Executive Officer, Futures Clearing Corporation and Chief Financial Officer. He will report to Shuman.
Donohue said, “Johannes’ extensive experience in Chinese markets and financial services, as well as his relationships with market participants in Asia, will be a true asset to CME as we develop additional growth opportunities in the Far East.”